BioCentury
ARTICLE | Clinical News

ALD-401: Interim Phase II data

October 22, 2012 7:00 AM UTC

Interim data from 10 patients in the double-blind, placebo-controlled, U.S. Phase II RECOVER-Stroke trial showed that an intracarotid infusion of 3 mL ALD-401 given 13-19 days post-stroke was safe wit...